Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-07-01
2008-07-01
Solola, Taofiq (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S403000, C514S447000, C546S305000, C548S372100, C549S063000
Reexamination Certificate
active
11446840
ABSTRACT:
The present invention relates to AMPA receptor potentiators of Formula I:formulations comprising them, methods for their use, and intermediates useful for their preparation.
REFERENCES:
patent: 2004/0087604 (2004-05-01), Tsuri et al.
patent: WO 98/33496 (1998-08-01), None
patent: WO 00/06083 (2000-02-01), None
patent: WO 01/42203 (2001-06-01), None
patent: WO 02/32858 (2002-04-01), None
patent: WO 02/098847 (2002-12-01), None
patent: WO 02/100851 (2002-12-01), None
patent: WO 03/010158 (2003-02-01), None
patent: WO 2005/070916 (2005-08-01), None
patent: WO 2006/015827 (2006-02-01), None
Ornstein et al., “Biarylproplsulfonamides as Novel, Potent Potentiators of 2-Amino-3-(5-methyl-3-hydroxyisoxazol-4-yl)-propanoic Acid (AMPA) Receptors,”J. Med. Chem., vol. 43, pp. 4354-4358 (2000).
Castano Mansanet Ana Maria
Cordier Frederic Laurent
Dominguez-Manzanares Esteban
Hong Jian Eric
Hornback William Joseph
Combs Tonya L.
Eli Lilly and Company
Solola Taofiq
LandOfFree
AMPA receptor potentiators does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with AMPA receptor potentiators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and AMPA receptor potentiators will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3935053